Non-Alcoholic Steatohepatitis (NASH) - A Review of a Crowded Clinical Landscape, Driven by a Complex Disease

Fraile, Julia M.Palliyil, SoumyaBarelle, CarolinePorter, Andrew J.Kovaleva, Marina2021-11-012021-11-012021-09-22Fraile, J M, Palliyil, S, Barelle, C, Porter, A J & Kovaleva, M 2021, 'Non-Alcoholic Steatohepatitis (NASH) - A Review of a Crowded Clinical Landscape, Driven by a Complex Disease', Drug design, development and therapy, vol. 15, pp. 3997-4009. https://doi.org/10.2147/DDDT.S3157241177-8881https://hdl.handle.net/2164/17423132997207engclinical trialliver fibrosisNAFLDNASHR MedicinePharmacologyPharmaceutical ScienceDrug DiscoveryRNon-Alcoholic Steatohepatitis (NASH) - A Review of a Crowded Clinical Landscape, Driven by a Complex DiseaseJournal item10.2147/DDDT.S315724http://www.scopus.com/inward/record.url?scp=85117296991&partnerID=8YFLogxK15